# The Use of AI to Improve Quality of OGD

> **NCT04883567** · — · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 210 (estimated)

## Conditions studied

- Dyspepsia
- Anemia
- Acid Reflux
- Dysphagia

## Interventions

- **DIAGNOSTIC_TEST:** The use of artificial intelligence system Cerebro

## Key facts

- **NCT ID:** NCT04883567
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883567, "The Use of AI to Improve Quality of OGD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04883567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*